UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Genetic and Histopathological Heterogeneity of Neuroblastoma and Precision Therapeutic Approaches for Extremely Unfavorable Histology Subgroups

Biomolecules (Basel, Switzerland), 2022-01, Vol.12 (1), p.79

2022

Volltextzugriff (PDF)

Clinical Relevance of CD4 Cytotoxic T Cells in High-Risk Neuroblastoma

Frontiers in immunology, 2021-04, Vol.12, p.650427-650427

2021

Volltextzugriff (PDF)

A Perspective on the CD47-SIRPA Axis in High-Risk Neuroblastoma

Current oncology (Toronto), 2024-06, Vol.31 (6), p.3212-3226

2024

Volltextzugriff (PDF)

Down-regulation of MYCN protein by CX-5461 leads to neuroblastoma tumor growth suppression

Journal of pediatric surgery, 2019-06, Vol.54 (6), p.1192-1197

2019

Volltextzugriff (PDF)

Neuroblastoma of undifferentiated subtype, prognostic significance of prominent nucleolar formation, and MYC/MYCN protein expression: A report from the Children's Oncology Group

Cancer, 2013-10, Vol.119 (20), p.3718-3726

2013

Volltextzugriff (PDF)

Transient treatment with epigenetic modifiers yields stable neuroblastoma stem cells resembling aggressive large-cell neuroblastomas

Proceedings of the National Academy of Sciences - PNAS, 2013-04, Vol.110 (15), p.6097-6102

2013

Volltextzugriff (PDF)

Local delivery of dinutuximab from lyophilized silk fibroin foams for treatment of an orthotopic neuroblastoma model

Cancer medicine (Malden, MA), 2020-04, Vol.9 (8), p.2891-2903

2020

Volltextzugriff (PDF)

High-Level Expression of Angiogenic Factors Is Associated with Advanced Tumor Stage in Human Neuroblastomas

Clinical cancer research, 2000-05, Vol.6 (5), p.1900-1908

2000

Volltextzugriff (PDF)

Age Inherently Links to Histology to Define Histoprognostic Classification of Peripheral Neuroblastic Tumors

Journal of clinical oncology, 2020-11, Vol.38 (31), p.3719-3720

2020

Volltextzugriff (PDF)

Macrophage-mediated anti-tumor immunity against high-risk neuroblastoma

Genes and immunity, 2022-06, Vol.23 (3-4), p.129-140

2022

Volltextzugriff (PDF)

Subgrouping of Unfavorable Histology Neuroblastomas With Immunohistochemistry Toward Precision Prognosis and Therapy Stratification

JCO precision oncology, 2019 (3), p.1-7

2019

Volltextzugriff (PDF)

Abstract 1218: A biological crosstalk between p53 and MYCN/MYC in neuroblastoma

Cancer research (Chicago, Ill.), 2015-08, Vol.75 (15_Supplement), p.1218-1218

2015

Volltextzugriff (PDF)

Resistance to TRAIL-induced apoptosis in primitive neuroectodermal brain tumor cells correlates with a loss of caspase-8 expression

Oncogene, 2000-09, Vol.19 (40), p.4604-4610

2000

Volltextzugriff (PDF)

Molecular dissection of TrkA signal transduction pathways mediating differentiation in human neuroblastoma cells

Oncogene, 2000-04, Vol.19 (16), p.2043-2051

2000

Volltextzugriff (PDF)

Favorable Neuroblastoma Genes and Molecular Therapeutics of Neuroblastoma

Clinical cancer research, 2004-09, Vol.10 (17), p.5837-5844

2004

Volltextzugriff (PDF)

Abstract 2497: Inhibitors of RNA Pol I and an aminoacyl-tRNA synthetase result in MYC and MYCN downregulation in MYC family protein-driven neuroblastoma cells

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.2497-2497

2018

Volltextzugriff (PDF)

Expression of the Neurotrophin Receptor TrkB Is Associated With Unfavorable Outcome in Wilms’ Tumor

Journal of clinical oncology, 2001-02, Vol.19 (3), p.689-696

2001

Volltextzugriff (PDF)

Abstract 4215: Small molecule compounds that destabilize stem cell factors

Cancer research (Chicago, Ill.), 2015-08, Vol.75 (15_Supplement), p.4215-4215

2015

Volltextzugriff (PDF)

De novo Identification of MIZ-1 (ZBTB17) Encoding a MYC-Interacting Zinc-Finger Protein as a New Favorable Neuroblastoma Gene

Clinical cancer research, 2007-10, Vol.13 (20), p.6001-6009

2007

Volltextzugriff (PDF)

Expression of TrkA, TrkB and TrkC in human neuroblastomas

Journal of neuro-oncology, 1997-01, Vol.31 (1-2), p.49-56

1997

Volltextzugriff (PDF)

Silk Reservoirs for Local Delivery of Cisplatin for Neuroblastoma Treatment: In Vitro and In Vivo Evaluations

Journal of pharmaceutical sciences, 2019-08, Vol.108 (8), p.2748-2755

2019

Volltextzugriff (PDF)

In vitro and in vivo evaluation of etoposide - silk wafers for neuroblastoma treatment

Journal of controlled release, 2018-09, Vol.285, p.162-171

2018

Volltextzugriff (PDF)

Implications of EPHB6, EFNB2, and EFNB3 Expressions in Human Neuroblastoma

Proceedings of the National Academy of Sciences - PNAS, 2000-09, Vol.97 (20), p.10936-10941

2000

Volltextzugriff (PDF)

Combined Replenishment of miR‐34a and let‐7b by Targeted Nanoparticles Inhibits Tumor Growth in Neuroblastoma Preclinical Models

Small (Weinheim an der Bergstrasse, Germany), 2020-05, Vol.16 (20), p.e1906426-n/a

2020

Volltextzugriff (PDF)

1 – 25 von 112

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(93)
Mit Volltextzugriff
(106)

Publikationsform

Sprache

Englisch
(112)

Erscheinungsjahr

n.n

Thema

Science & Technology
(74)
Life Sciences & Biomedicine
(69)
Humans
(62)
Oncology
(42)
Neuroblastoma
(39)
Biological And Medical Sciences
(31)
Neuroblastoma - Genetics
(27)
Neuroblastoma - Pathology
(27)
Animals
(24)
Tumor Cells, Cultured
(23)
Medical Sciences
(19)
Mice
(19)
Gene Expression Regulation, Neoplastic
(17)
Neuroblastoma - Metabolism
(17)
Tumors
(16)
Biochemistry & Molecular Biology
(14)
Genetics & Heredity
(13)
Pediatrics
(13)
Transfection
(13)
Fundamental And Applied Biological Sciences. Psychology
(12)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Genetic and Histopathological Heterogeneity of Neuroblastoma and Precision Therapeutic Approaches for Extremely Unfavorable Histology Subgroups

Clinical Relevance of CD4 Cytotoxic T Cells in High-Risk Neuroblastoma

A Perspective on the CD47-SIRPA Axis in High-Risk Neuroblastoma

Down-regulation of MYCN protein by CX-5461 leads to neuroblastoma tumor growth suppression

Neuroblastoma of undifferentiated subtype, prognostic significance of prominent nucleolar formation, and MYC/MYCN protein expression: A report from the Children's Oncology Group

Transient treatment with epigenetic modifiers yields stable neuroblastoma stem cells resembling aggressive large-cell neuroblastomas

MYC-family protein overexpression and prominent nucleolar formation represent prognostic indicators and potential therapeutic targets for aggressive high-MKI neuroblastomas: a report from the children's oncology group

Local delivery of dinutuximab from lyophilized silk fibroin foams for treatment of an orthotopic neuroblastoma model

High-Level Expression of Angiogenic Factors Is Associated with Advanced Tumor Stage in Human Neuroblastomas

Age Inherently Links to Histology to Define Histoprognostic Classification of Peripheral Neuroblastic Tumors

Macrophage-mediated anti-tumor immunity against high-risk neuroblastoma

Subgrouping of Unfavorable Histology Neuroblastomas With Immunohistochemistry Toward Precision Prognosis and Therapy Stratification

Abstract 1218: A biological crosstalk between p53 and MYCN/MYC in neuroblastoma

Resistance to TRAIL-induced apoptosis in primitive neuroectodermal brain tumor cells correlates with a loss of caspase-8 expression

Molecular dissection of TrkA signal transduction pathways mediating differentiation in human neuroblastoma cells

Favorable Neuroblastoma Genes and Molecular Therapeutics of Neuroblastoma

Abstract 2497: Inhibitors of RNA Pol I and an aminoacyl-tRNA synthetase result in MYC and MYCN downregulation in MYC family protein-driven neuroblastoma cells

Expression of the Neurotrophin Receptor TrkB Is Associated With Unfavorable Outcome in Wilms’ Tumor

Abstract 4215: Small molecule compounds that destabilize stem cell factors

De novo Identification of MIZ-1 (ZBTB17) Encoding a MYC-Interacting Zinc-Finger Protein as a New Favorable Neuroblastoma Gene

Expression of TrkA, TrkB and TrkC in human neuroblastomas

Silk Reservoirs for Local Delivery of Cisplatin for Neuroblastoma Treatment: In Vitro and In Vivo Evaluations

In vitro and in vivo evaluation of etoposide - silk wafers for neuroblastoma treatment

Implications of EPHB6, EFNB2, and EFNB3 Expressions in Human Neuroblastoma

Combined Replenishment of miR‐34a and let‐7b by Targeted Nanoparticles Inhibits Tumor Growth in Neuroblastoma Preclinical Models

Suchergebnisse filtern